Medical Fair China 2024 was successfully held at Suzhou International Expo Center on August 23rd. With the theme of "Supply chain leading medical innovation", the exhibition brought together 320 well-known enterprises in the field of medical device manufacturing, production and research, displayed many groundbreaking and innovative exhibits, showed the cutting-edge trends and future development direction of the industry, and attracted 11,320 professional visitors, experts and scholars and industry professionals to actively participate.
At this exhibition, PT MedTech met abundant R&D and procurement friends from domestic medical brands, as well as experts and scholars in the industry, and also attracted some consultation and communication from overseas visitors such as Russia, Australia, India and Japan.
The emerging market represented by China is the world's most potential medical device market, not only for its product popularity demand but also for its upgrading demands. In recent years, the rapid growth rate of Chinese market make itself an important global medical device production base, accounting for about 14% of the global medical device marketing share. At the meantime, due to domestic CDMO market still on its start-up stage, still in the lack of high-end medical device CDMO platform with full life cycle service capabilities from research and development, production to license obtain. Especially in the field of minimally invasive surgery, current situation is that most manufacturers need to complete the integration of outsourcing resources through the entire tens to hundreds of suppliers, brings big challenge to supply chain management ability, slows down the development cycle, and also brings much potential risks on product quality. Therefore, there is an urgent demands for contract manufacturers with highly integrated production capabilities, innovative engineering capabilities and world-class supply chain management and systematic quality control. PT MedTech is a one-stop CMO for medical devices OEMs with such comprehensive capabilities. At the same time, MAH policy has its pilot of the medical device in Shanghai in 2017, expanded to 21 provinces by 2019, allowing different subjects to cooperate in product registration and manufacturing in the same medical device product, which greatly encourages the enthusiasm of enterprises to invest resources on research, development and innovation.
Through this exhibition, PT MedTech further demonstrated its positioning in the field of minimally invasive medical device contract manufacturing industry, well recognized by more and more customers in its one-stop processing and manufacturing capabilities. Providing reliable quality assurance in the launch of MAH system, we will continue to support domestic medical device OEMs with professional and global standard service and sustainable high quality products!
